Journal: Experimental Biology and Medicine
Article Title: Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts
doi: 10.1177/1535370218761628
Figure Lengend Snippet: Relative changes in gene expression due to ECM rigidity and TGF-β1 treatment. Human cardiac fibroblasts were cultured on low, moderate, and high PDMS-coated coated coverslips with or without 2 ng/mL TGF-β1 for one, three, and five days. RT-PCR was used to quantify the relative expression of (a) ACTA2, (b) POSTN, (c) FAP, (d) FSP1, and (e) GJA1. All data were normalized to high PDMS control group on Day 1. (n = 4, bars indicate mean ±standard error of the mean, *P < 0.05 and **P < 0.01 according to one-way ANOVA and Tukey’s test for multiple comparisons. For detailed statistical analysis, see Supplementary Tables S5 to S9). (A color version of this figure is available in the online journal.)
Article Snippet: Cell culture Primary human adult cardiac fibroblasts (Lot 3131, Cell Applications Inc., San Diego, CA, USA) were thawed into a 75 cm 2 cell culture flask with fibroblast growth medium, consisting of low glucose DMEM (1 g/L glucose) supplemented with 10% v/v fetal bovine serum (FBS) (Gibco, Waltham, MA, USA) and 1% v/v penicillin-streptomycin solution (10,000 U/mL penicillin, 10,000 μg/mL streptomycin).
Techniques: Gene Expression, Cell Culture, Reverse Transcription Polymerase Chain Reaction, Expressing, Control